# MYHIBBIN

NDC: 24338-018
Generic name: MYCOPHENOLATE MOFETIL
Labeler / Manufacturer: Azurity Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: SUSPENSION
Routes: ORAL
Marketing started: 20240610

FDA application: NDA216482

## Active ingredients

- MYCOPHENOLATE MOFETIL: 200 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"24338-018"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=24338-018
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d9af72d6-7b3e-4c08-94b9-1d8b499cb7f9